ENTITY
Livzon Pharmaceutical Group

Livzon Pharmaceutical Group (1513 HK)

67
Analysis
Health CareChina
Livzon Pharmaceutical Group Inc. develops and manufactures pharmaceutical products, including chemical medicines, bio-chemical medicines, biological engineering medicines, chemical compound crude medicines, antibiotics, micro-ecological preparations, patent Chinese medicines, and diagnosis reagents etc.
more
Refresh
bearishMSCI ACWI Index
27 Mar 2020 09:25

Global Equity Strategy: Initial Low Established

Several equity indexes and indicators we watch are telling us an initial primary low has been established for global equities (ACWI-US). At the...

Logo
449 Views
Share
24 Feb 2020 21:13

Full Circulation Of H Shares: Signs Of Life

On the 29 December 2017, the China Securities Regulatory Commission's ("CSRC") announced it would launch the H-share Full Circulation Pilot...

Logo
387 Views
Share
bullishMSCI ACWI Index
22 Nov 2019 05:57

Global Equity Strategy: Health Care Hitting On All Cylinders - Overweight

Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the...

Logo
390 Views
Share
bullishChina Tower
19 Nov 2019 18:28

CSRC Green Lights Full Circulation Of H Shares

Back in June last year, I flagged (Legend's Conversion of Domestic Shares) 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry...

Logo
815 Views
Share
23 Sep 2019 10:59

HK Connect Ideas: First Weekly Outflows in 19 Weeks, SMIC, Auto Sector (2019-09-20)

In our weekly HK Connect Snippet series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as...

Logo
365 Views
Share
x